161 related articles for article (PubMed ID: 27754452)
1. Mreg Activity in Tumor Response to Photodynamic Therapy and Photodynamic Therapy-Generated Cancer Vaccines.
Korbelik M; Banáth J; Zhang W
Cancers (Basel); 2016 Oct; 8(10):. PubMed ID: 27754452
[TBL] [Abstract][Full Text] [Related]
2. Calreticulin as cancer treatment adjuvant: combination with photodynamic therapy and photodynamic therapy-generated vaccines.
Korbelik M; Banáth J; Saw KM; Zhang W; Čiplys E
Front Oncol; 2015; 5():15. PubMed ID: 25692097
[TBL] [Abstract][Full Text] [Related]
3. Interaction of acid ceramidase inhibitor LCL521 with tumor response to photodynamic therapy and photodynamic therapy-generated vaccine.
Korbelik M; Banáth J; Zhang W; Saw KM; Szulc ZM; Bielawska A; Separovic D
Int J Cancer; 2016 Sep; 139(6):1372-8. PubMed ID: 27136745
[TBL] [Abstract][Full Text] [Related]
4. Immunoregulatory Cell Depletion Improves the Efficacy of Photodynamic Therapy-Generated Cancer Vaccines.
Korbelik M; Banáth J; Saw KM
Int J Mol Sci; 2015 Nov; 16(11):27005-14. PubMed ID: 26569233
[TBL] [Abstract][Full Text] [Related]
5. Generation of effective antitumor vaccines using photodynamic therapy.
Gollnick SO; Vaughan L; Henderson BW
Cancer Res; 2002 Mar; 62(6):1604-8. PubMed ID: 11912128
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic Therapy Supported by Antitumor Lipids.
Korbelik M
Pharmaceutics; 2023 Dec; 15(12):. PubMed ID: 38140064
[TBL] [Abstract][Full Text] [Related]
7. Exploitation of immune response-eliciting properties of hypocrellin photosensitizer SL052-based photodynamic therapy for eradication of malignant tumors.
Korbelik M; Merchant S; Huang N
Photochem Photobiol; 2009; 85(6):1418-24. PubMed ID: 19709384
[TBL] [Abstract][Full Text] [Related]
8. N-dihydrogalactochitosan as immune and direct antitumor agent amplifying the effects of photodynamic therapy and photodynamic therapy-generated vaccines.
Korbelik M; Banáth J; Zhang W; Gallagher P; Hode T; Lam SSK; Chen WR
Int Immunopharmacol; 2019 Oct; 75():105764. PubMed ID: 31352327
[TBL] [Abstract][Full Text] [Related]
9. Complement activation cascade and its regulation: relevance for the response of solid tumors to photodynamic therapy.
Korbelik M; Cecic I
J Photochem Photobiol B; 2008 Oct; 93(1):53-9. PubMed ID: 18715798
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy-mediated immune response against subcutaneous mouse tumors.
Korbelik M; Dougherty GJ
Cancer Res; 1999 Apr; 59(8):1941-6. PubMed ID: 10213504
[TBL] [Abstract][Full Text] [Related]
11. Combination of Photodynamic Therapy and Specific Immunotherapy Efficiently Eradicates Established Tumors.
Kleinovink JW; van Driel PB; Snoeks TJ; Prokopi N; Fransen MF; Cruz LJ; Mezzanotte L; Chan A; Löwik CW; Ossendorp F
Clin Cancer Res; 2016 Mar; 22(6):1459-68. PubMed ID: 26546617
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide production by tumour tissue: impact on the response to photodynamic therapy.
Korbelik M; Parkins CS; Shibuya H; Cecic I; Stratford MR; Chaplin DJ
Br J Cancer; 2000 Jun; 82(11):1835-43. PubMed ID: 10839299
[TBL] [Abstract][Full Text] [Related]
13. Confocal fluorescence imaging enables noninvasive quantitative assessment of host cell populations in vivo following photodynamic therapy.
Mitra S; Mironov O; Foster TH
Theranostics; 2012; 2(9):840-9. PubMed ID: 23082097
[TBL] [Abstract][Full Text] [Related]
14. Combination of photodynamic therapy (PDT) and anti-tumor immunity in cancer therapy.
Hwang HS; Shin H; Han J; Na K
J Pharm Investig; 2018; 48(2):143-151. PubMed ID: 30680248
[TBL] [Abstract][Full Text] [Related]
15. Role of the immune system in mediating the antitumor effect of benzophenothiazine photodynamic therapy.
Hendrzak-Henion JA; Knisely TL; Cincotta L; Cincotta E; Cincotta AH
Photochem Photobiol; 1999 May; 69(5):575-81. PubMed ID: 10333764
[TBL] [Abstract][Full Text] [Related]
16. Anti-angiogenic treatment (Bevacizumab) improves the responsiveness of photodynamic therapy in colorectal cancer.
Peng CL; Lin HC; Chiang WL; Shih YH; Chiang PF; Luo TY; Cheng CC; Shieh MJ
Photodiagnosis Photodyn Ther; 2018 Sep; 23():111-118. PubMed ID: 29894822
[TBL] [Abstract][Full Text] [Related]
17. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.
Bellnier DA; Gollnick SO; Camacho SH; Greco WR; Cheney RT
Cancer Res; 2003 Nov; 63(22):7584-90. PubMed ID: 14633671
[TBL] [Abstract][Full Text] [Related]
18. Detection of Treatment Success after Photodynamic Therapy Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
Schreurs TJL; Jacobs I; Nicolay K; Prompers JJ; Strijkers GJ
Theranostics; 2017; 7(19):4643-4657. PubMed ID: 29187893
[TBL] [Abstract][Full Text] [Related]
19. Optimization of Whole Tumor Cell Vaccines by Interaction with Phagocytic Receptors.
Korbelik M
Vaccines (Basel); 2021 Aug; 9(8):. PubMed ID: 34452029
[TBL] [Abstract][Full Text] [Related]
20. Contribution of myeloid and lymphoid host cells to the curative outcome of mouse sarcoma treatment by photodynamic therapy.
Korbelik M; Cecic I
Cancer Lett; 1999 Mar; 137(1):91-8. PubMed ID: 10376798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
